Putative regulation mechanism for the MSTN gene by a CpG island generated by the SINE marker Ins227bp.
Authors: van den Hoven René, Gür Emre, Schlamanig Manuela, Hofer Martin, Onmaz Ali Cesur, Steinborn Ralf
Journal: BMC veterinary research
Summary
# Editorial Summary Myostatin gene (MSTN) polymorphisms have been linked to racing aptitude in elite Thoroughbreds, but their relevance to the broader racing population remained unclear. Van den Hoven and colleagues genotyped three MSTN markers—including a 227 bp SINE insertion (Ins227bp) in the promoter region and an intronic SNP—in a cohort of average-status racing horses using ARMS-qPCR and amplicon melting techniques, whilst conducting in silico analysis to identify whether the Ins227bp insertion creates novel CpG islands for DNA methylation or alters transcription factor binding sites. The insertion polymorphism was found to generate a putative CpG island capable of regulating myostatin expression through epigenetic mechanisms, suggesting a plausible molecular pathway by which this marker influences muscle development and athletic phenotype. These findings indicate that MSTN genotyping may have practical value in identifying performance predisposition across different racing populations and environments, though field validation of the proposed methylation-based regulation would strengthen clinical application. For equine practitioners and coaches, incorporating MSTN marker analysis into pre-purchase or talent identification protocols could help stratify athletic potential, particularly when combined with traditional assessment methods.
Read the full abstract on PubMed
Practical Takeaways
- •Genotyping for the Ins227bp marker and associated SNPs could potentially help identify sprint versus endurance aptness in young Thoroughbreds before training investment
- •Understanding MSTN regulation through DNA methylation and transcription factor binding offers a molecular basis for breeding decisions targeting specific racing distances
- •These markers may be more relevant for predicting performance in average racing populations than previously studied in elite horses
Key Findings
- •SINE marker Ins227bp insertion polymorphism in MSTN promoter is associated with racing distance aptness in Thoroughbreds
- •Ins227bp generates a novel CpG island that could serve as a DNA methylation target, providing a putative regulatory mechanism for MSTN expression
- •The intronic SNP g.66493737 T→C and adjacent BIEC2-417495 marker show prevalence variation in average Thoroughbreds across different racing industries
- •Computational analysis identified potential transcription factor binding sites created by the Ins227bp insertion